Medpace Holdings EBITDA 2014-2024 | MEDP

Medpace Holdings annual and quarterly EBITDA history from 2014 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Medpace Holdings EBITDA for the quarter ending September 30, 2024 was $0.120B, a 30.51% increase year-over-year.
  • Medpace Holdings EBITDA for the twelve months ending September 30, 2024 was $0.438B, a 24.58% increase year-over-year.
  • Medpace Holdings 2023 annual EBITDA was $0.363B, a 20.63% increase from 2022.
  • Medpace Holdings 2022 annual EBITDA was $0.301B, a 37% increase from 2021.
  • Medpace Holdings 2021 annual EBITDA was $0.22B, a 18.22% increase from 2020.
Medpace Holdings Annual EBITDA
(Millions of US $)
2023 $363
2022 $301
2021 $220
2020 $186
2019 $151
2018 $133
2017 $103
2016 $113
2015 $93
2014 $75
2013 $91
Medpace Holdings Quarterly EBITDA
(Millions of US $)
2024-09-30 $120
2024-06-30 $112
2024-03-31 $111
2023-12-31 $94
2023-09-30 $92
2023-06-30 $85
2023-03-31 $92
2022-12-31 $82
2022-09-30 $84
2022-06-30 $66
2022-03-31 $69
2021-12-31 $61
2021-09-30 $59
2021-06-30 $48
2021-03-31 $53
2020-12-31 $60
2020-09-30 $51
2020-06-30 $35
2020-03-31 $40
2019-12-31 $41
2019-09-30 $35
2019-06-30 $41
2019-03-31 $34
2018-12-31 $40
2018-09-30 $30
2018-06-30 $33
2018-03-31 $30
2017-12-31 $18
2017-09-30 $29
2017-06-30 $28
2017-03-31 $28
2016-12-31 $28
2016-09-30 $28
2016-06-30 $29
2016-03-31 $28
2015-12-31
2015-09-30 $7
2014-12-31
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $9.789B $1.886B
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
Revvity (RVTY) United States $13.376B 23.24
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Doximity (DOCS) United States $9.620B 56.63
Charles River Laboratories (CRL) United States $9.516B 18.39
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00